Basilea Pharmaceutica AG
BPMUF
$77.40
$11.9018.17%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.84% | -32.58% | -44.74% | 49.64% | 9,803.52% |
| Total Depreciation and Amortization | 10.52% | 14.71% | 16.08% | 16.48% | 18.30% |
| Total Amortization of Deferred Charges | -31.41% | -19.06% | -14.72% | -50.59% | -65.23% |
| Total Other Non-Cash Items | 209.49% | 283.53% | 167.41% | 154.65% | 135.28% |
| Change in Net Operating Assets | -1,526.13% | -75.21% | 55.61% | -57.18% | -103.29% |
| Cash from Operations | -20.89% | -14.65% | -10.95% | 71.88% | 693.39% |
| Capital Expenditure | -88.11% | -78.55% | -66.48% | -65.04% | -65.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | -100.00% |
| Other Investing Activities | -63.51% | -132.11% | -217.01% | -37.09% | 37.07% |
| Cash from Investing | -86.32% | -132.39% | -203.92% | -239.43% | -345.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -12.84% | -59.47% | -71.87% | -76.87% | -80.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 18.13% | -127.58% | -105,219.05% | -14,399.22% | -6,317.80% |
| Cash from Financing | 12.34% | -33.78% | -72.34% | 43.53% | 72.05% |
| Foreign Exchange rate Adjustments | 59.63% | -140.00% | -157.56% | -658.00% | -132.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.69% | -28.43% | -32.56% | 483.21% | 247.77% |